cephalothin has been researched along with beta-lactams in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adriaens, P; Anné, J; Dumon, L; Eyssen, H | 1 |
| Alford, RH; Harris, LF; Jackson, RT | 1 |
| Bergström, S; Normark, S | 1 |
| Mitsuhashi, S; Une, T | 1 |
| Kraus, LL; Lewis, RP; Meyer, RD | 1 |
| Greenwood, D; O'Grady, F | 2 |
| Hamilton-Miller, JM; Ramsay, J | 1 |
| Labia, R | 1 |
| Chanter, KV; Harris, AM; Kirby, SM; Marshall, MJ; O'Callaghan, CH; Ross, GW | 1 |
| Bobrowski, M; Borowski, E | 1 |
| McNamara, BT; Meyer, RD; Pasiecznik, KA | 1 |
| de las Parras, PJ; Garcia, AA; Martínez, JH; Navarro, PG | 1 |
| Arakawa, Y; Goto, M; Harada, K; Higashi, T; Kawanami, A; Mifune, S; Mori, H; Nakayama, H; Yamaguchi, Y; Yasuzawa, H | 1 |
| Bertrand, X; Lallemand-De-Conto, S; Talon, D; Thouverez, M | 1 |
| Das, S; Gayen, JR; Ghosh, K; Pal, A; Rosazza, JP; Samanta, TB | 1 |
| Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M | 1 |
| Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B | 1 |
| Kechrid, A; Réjiba, S | 1 |
| Bonomo, RA; Caselli, E; Drawz, SM; Prati, F; Taracila, M | 1 |
| Gabay, D; Ghannoum, M; Harding, CV; Hoch, W; Kuo, D; Long, L; Nagy, N; Shoham, M; Viswanathan, R; Yu, G | 1 |
21 other study(ies) available for cephalothin and beta-lactams
| Article | Year |
|---|---|
Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Cephalosporins; Cephalothin; Drug Interactions; Penicillin G; Penicillins | 1979 |
Sodium clavulanate potentiation of cephalosporin activity against clinical isolates of cephalothin-resistant Klebsiella pneumoniae.
Topics: Amidohydrolases; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Klebsiella pneumoniae; Microbial Sensitivity Tests; Time Factors | 1978 |
Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalothin; Chromosomes, Bacterial; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans | 1979 |
Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
Topics: Animals; Bacteria; beta-Lactams; Cefazolin; Cefoxitin; Cephalosporinase; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Stability; Enterobacteriaceae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillinase | 1977 |
Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins | 1976 |
Lysis enhancement: a novel form of interaction between beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriolysis; beta-Lactams; Cephalexin; Cephaloridine; Cephalothin; Drug Synergism; Escherichia coli; Nephelometry and Turbidimetry; Penicillin Resistance | 1975 |
Synergism between beta-lactam antibiotics: a test of theoretical predictions made with Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Cephalothin; Drug Synergism; Kinetics; Penicillin G; Penicillin Resistance; Penicillin V; Staphylococcus; Time Factors | 1973 |
[Enzyme-substrate behavior. Introduction of the concept of enzymatic stability in the case of beta-lactamases].
Topics: Amidohydrolases; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Carbenicillin; Cephalexin; Cephaloridine; Cephalothin; Escherichia coli; Kinetics; Penicillin G; Penicillin Resistance; Penicillin V; Penicillinase; Pseudomonas aeruginosa | 1974 |
Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.
Topics: Amides; Ampicillin; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactams; Carbenicillin; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Densitometry; Escherichia coli; Microscopy, Electron, Scanning; Osmolar Concentration; Penicillins; Proteus; Proteus mirabilis; Time Factors | 1973 |
Comparison of assay techniques for beta-lactamase activity.
Topics: beta-Lactams; Biological Assay; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cloxacillin; Enterobacteriaceae; Evaluation Studies as Topic; Hydroxylamines; Iodine; Kinetics; Klebsiella; Methicillin; Methods; Oxidation-Reduction; Penicillin G; Penicillinase; Spectrophotometry, Ultraviolet | 1973 |
Interaction between carbenicillin and beta-lactamases from Gram-negative bacteria.
Topics: Ampicillin; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Cephaloridine; Cephalothin; Culture Media; Enterobacteriaceae; Enzyme Induction; Escherichia coli; Hydrolysis; Klebsiella; Klebsiella pneumoniae; Penicillin G; Penicillin V; Penicillinase; Penicillins; Proteus mirabilis; Proteus vulgaris; Pseudomonas aeruginosa | 1971 |
In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefoxitin; Cephalothin; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
Beta-lactam degradation catalysed by Cd2+ ion in methanol.
Topics: Anti-Bacterial Agents; beta-Lactams; Cadmium; Cephalothin; Kinetics; Methanol; Penicillin G; Penicillin V | 1999 |
Dependence of hydrolysis of beta-lactams with a zinc(II)-beta-lactamase produced from Serratia marcescens (IMP-1) on pH and concentration of zinc(II) ion: dissociation of Zn(II) from IMP-1 in acidic medium.
Topics: Anti-Bacterial Agents; beta-Lactams; Catalysis; Cephalothin; Hydrogen-Ion Concentration; Hydrolysis; Imipenem; Kinetics; Serratia marcescens; Zinc | 2003 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; Cephalothin; Ciprofloxacin; Clavulanic Acid; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Genotype; Humans; Male; Middle Aged; Nalidixic Acid; Phenotype; Selection, Genetic; Urinary Tract Infections | 2004 |
Purification, substrate specificity, and N-terminal amino acid sequence analysis of a beta-lactamase-free penicillin amidase from Alcaligenes sp.
Topics: Alcaligenes; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalothin; Circular Dichroism; Molecular Sequence Data; Penicillin Amidase; Sequence Analysis, Protein; Substrate Specificity | 2004 |
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2006 |
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2007 |
Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalothin; Child; Escherichia coli; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Penicillins; Tunisia | 2007 |
Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding Sites; Boronic Acids; Cephalosporinase; Cephalosporins; Cephalothin; Enzyme Inhibitors; Models, Molecular; Molecular Sequence Data; Protein Binding; Pseudomonas aeruginosa; Sequence Alignment; Substrate Specificity | 2011 |
Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Line; Cephalothin; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nafcillin; Quorum Sensing; Wound Healing | 2015 |